PURPOSE: Women with child wish are advised to take folic acid supplements to reduce the risk for spina bifida. However, there is less evidence for this protective effect in women using valproic acid (VPA). We investigated the effect of folic acid in women exposed to VPA in the first trimester of pregnancy. METHODS: A case-control study was performed with data from a population-based registry of congenital malformations. Our cases were spina bifida registrations and all other malformed registrations (excluding folic acid sensitive malformations) were used as controls. RESULTS: The ORs for the effect of correct folic acid use were calculated among antiepileptic drug (AED) unexposed pregnancies 0.5 [95%CI: 0.3-0.7] and among VPA exposed pregnancies 1.0 [95%CI: 0.1-7.6]. DISCUSSION: Due to power-reasons, we cannot conclude that folic acid has no effect on the risk for spina bifida among VPA exposed pregnancies. Although for AED unexposed pregnancies we found a decreased risk. Results from (animal) studies support a biologically plausible association between VPA, folic acid and spina bifida. While folic acid might not be able to reduce the risk for lower spina bifida lesions caused by VPA, the use of folic acid might be important to reduce the risk for higher, folic acid sensitive spina bifida lesions. Further research is needed to get more insight in the most effective form and dose of FA in women that use VPA to reduce the risk for (higher forms of) spina bifida. 2010 John Wiley & Sons, Ltd.
PURPOSE:Women with child wish are advised to take folic acid supplements to reduce the risk for spina bifida. However, there is less evidence for this protective effect in women using valproic acid (VPA). We investigated the effect of folic acid in women exposed to VPA in the first trimester of pregnancy. METHODS: A case-control study was performed with data from a population-based registry of congenital malformations. Our cases were spina bifida registrations and all other malformed registrations (excluding folic acid sensitive malformations) were used as controls. RESULTS: The ORs for the effect of correct folic acid use were calculated among antiepileptic drug (AED) unexposed pregnancies 0.5 [95%CI: 0.3-0.7] and among VPA exposed pregnancies 1.0 [95%CI: 0.1-7.6]. DISCUSSION: Due to power-reasons, we cannot conclude that folic acid has no effect on the risk for spina bifida among VPA exposed pregnancies. Although for AED unexposed pregnancies we found a decreased risk. Results from (animal) studies support a biologically plausible association between VPA, folic acid and spina bifida. While folic acid might not be able to reduce the risk for lower spina bifida lesions caused by VPA, the use of folic acid might be important to reduce the risk for higher, folic acid sensitive spina bifida lesions. Further research is needed to get more insight in the most effective form and dose of FA in women that use VPA to reduce the risk for (higher forms of) spina bifida. 2010 John Wiley & Sons, Ltd.
Authors: Kerina J Denny; Angela Jeanes; Kristin Fathe; Richard H Finnell; Stephen M Taylor; Trent M Woodruff Journal: Birth Defects Res A Clin Mol Teratol Date: 2013-09
Authors: Darya Akimova; Bogdan J Wlodarczyk; Ying Lin; M Elizabeth Ross; Richard H Finnell; Qiuying Chen; Steven S Gross Journal: Birth Defects Res Date: 2017-01-30 Impact factor: 2.344
Authors: Julie M Petersen; Samantha E Parker; Corey M Benedum; Allen A Mitchell; Sarah C Tinker; Martha M Werler Journal: Birth Defects Res Date: 2019-08-21 Impact factor: 2.661
Authors: Lu Ban; Kate M Fleming; Pat Doyle; Liam Smeeth; Richard B Hubbard; Linda Fiaschi; Laila J Tata Journal: PLoS One Date: 2015-07-06 Impact factor: 3.240
Authors: Richard H Finnell; Carlo Donato Caiaffa; Sung-Eun Kim; Yunping Lei; John Steele; Xuanye Cao; Gabriel Tukeman; Ying Linda Lin; Robert M Cabrera; Bogdan J Wlodarczyk Journal: Front Genet Date: 2021-05-10 Impact factor: 4.599
Authors: Babak Khoshnood; Maria Loane; Hermien de Walle; Larraitz Arriola; Marie-Claude Addor; Ingeborg Barisic; Judit Beres; Fabrizio Bianchi; Carlos Dias; Elizabeth Draper; Ester Garne; Miriam Gatt; Martin Haeusler; Kari Klungsoyr; Anna Latos-Bielenska; Catherine Lynch; Bob McDonnell; Vera Nelen; Amanda J Neville; Mary T O'Mahony; Annette Queisser-Luft; Judith Rankin; Anke Rissmann; Annukka Ritvanen; Catherine Rounding; Antonin Sipek; David Tucker; Christine Verellen-Dumoulin; Diana Wellesley; Helen Dolk Journal: BMJ Date: 2015-11-24